Researchers can now predict the odds of experimental drugs succeeding in clinical trials,thanks to a modern data-driven approach developed by Weill Cornell Medicine scientists. The method detects toxic side effects that may disqualify drugs from human use, giving drug developers an early warning before initiating clinical trials, or according to a modern study published Sept. 15 in Cell Chemical Biology.
Source: phys.org